Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BNTX has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
BNTX stock price ended at $102.02 on , after losing-15.36%
The Biontech SE stock price decreased by -15.36% on the last trading day (), dropping from 118.73 to 102.02. Throughout the last trading session, the stock experienced a fluctuation of 27.43% , ranging from a day low of $93.1701 to a day high of 118.73. The price has declined in 3 of the last 10 days, resulting in a total change of 9.56% during this period. On the last day, trading volume decrease by 4.93M shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 6.44M shares were traded, amounting to approximately 656.31M.
BNTX Technical Signals
BNTX(Biontech SE Corp) has buy signals and sell signals now. The average turnover of BNTX over the last 5 trading days is NaN. Overall, the technical indicator signals lean more toward a outlook in the mid-term.
BNTX Moving Average Analysis
Biontech SE's overall moving average trend leans more bearish as of Monday, April 28, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $, and $. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $, and $. A break-down below any of these levels will issue sell signals.
BNTX Short Selling Analysis
The short sale ratio of Biontech SE(BNTX) as of is %, dropping from last trading day. With decreasing price from to .
Technical Signal
Technical Signals Summary
Sell
Buy
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
Bullish Signals
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No Data
Bearish Signals
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
No Data
BNTX
Name
Similarity
Up/Down
No Data
BNTX Seasonality Analysis
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Biontech SE (BNTX.O) stock in has the highest probability of a positive return (%), while has the lowest probability (%).
Performance Seasonality
The chart shows Biontech SE. (BNTX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Biontech SE (BNTX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BNTX has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Biontech SE (BNTX.O) stock in a year?
The radar chart shows that buying Biontech SE (BNTX.O) stock in has the highest probability of a positive return (33.33%), while has the lowest probability (33.33%).
How has Biontech SE. (BNTX)'s stock price performed over the past three years?
BNTX's stock price fell by in Invalid Date,in by
Which bull technical signals does BNTX have?
Bullish technical signals of BNTX include:
Which bearish technical signals does BNTX have?
Bearish technical signals of BNTX include:
Is BNTX a buy based on overall technical signals summary?
BNTX has 3 buy signals and 7 sell signals now. Overall the technical rating for BNTX is . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BNTX.
What is the trend of Biontech SE (BNTX)'s moving average?
Biontech SE's overall moving average trend leans more bearish as of April 28 2025, with 1 negative signals and 3 positive signal.
What is price prediction for BNTX stock next month?
The price prediction chart for Biontech SE (BNTX.O) stock, as of Invalid Date, forecasts a % change over the next month, based on its high correlation with stock patterns. The similarity between their price movements over the analyzed periods is %. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for BNTX Stock?
### **Price Prediction for BNTX Stock in 2025**
Based on analyst consensus and technical analysis, BNTX stock is predicted to reach **$145 to $171** in 2025.
The average analyst price target is **$145**, representing a **48.77% upside** from current levels.
This prediction is supported by BioNTech's strong oncology pipeline and positive analyst sentiment.
What is price prediction 2030 for BNTX Stock?
### **Price Prediction for BNTX Stock in 2030**
Based on current trends, analyst expectations, and the company's pipeline, BNTX stock is predicted to reach **$150 to $200 by 2030**.
- **Reason 1**: Strong analyst consensus with price targets ranging from $130 to $171, indicating confidence in BioNTech's growth potential.
- **Reason 2**: Robust oncology pipeline, including BNT327, expected to drive long-term revenue growth and diversification beyond COVID-19 vaccines.
- **Reason 3**: Positive technical indicators and Fibonacci levels suggesting upward momentum in the medium term.
{RATING:symbol=BNTX, type=0}